🇺🇸 FDA
Patent

US 11866710

Transmembrane protease, serine 6 (TMPRSS6) iRNA compositions and methods of use thereof

granted A61KA61K47/549

Quick answer

US patent 11866710 (Transmembrane protease, serine 6 (TMPRSS6) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K47/549